Smoking and schizophrenia: Abnormal nicotinic receptor expression

European Journal of Pharmacology

Volumn 393, Issue 1-3, 2000, Pages 237-242

  Leonard, Sherry ^a,b   Breese, Charles ^c   Adams, Catherine ^a   Benhammou, Khalid ^a   Gault, Judith ^a   Stevens, Karen ^a   Lee, Michael ^a   Adler, Lawrence ^a   Olincy, Ann ^a   Ross, Randal ^a   Freedman, Robert ^a,b  

^a UNIVERSITY OF COLORADO   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

^c AUBURN UNIVERSITY   (United States)

Author keywords

Gene duplication; Neutrophil; Nicotine; Nicotinic receptor; Schizophrenia; Smoking

Indexed keywords

NICOTINE; NICOTINIC RECEPTOR; RECEPTOR SUBUNIT;

ANIMAL MODEL; AUTOPSY; BLOOD CELL; CONFERENCE PAPER; CONTROLLED STUDY; EVOKED AUDITORY RESPONSE; GENE LOCUS; HUMAN; HUMAN CELL; HUMAN EXPERIMENT; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MENTAL DISEASE; MOLECULAR CLONING; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RECEPTOR DENSITY; SCHIZOPHRENIA; SMOKING;

ANIMALS; BRAIN; CHROMOSOME MAPPING; CHROMOSOMES, HUMAN, PAIR 15; CLONING, MOLECULAR; DISEASE MODELS, ANIMAL; GENE EXPRESSION; HUMANS; LEUKOCYTES, MONONUCLEAR; MICE; NICOTINE; RECEPTORS, NICOTINIC; SCHIZOPHRENIA; SMOKING;

EID: 0034732116     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0014-2999(00)00035-2     Document Type: Conference Paper

References (73)

1. Adler L.E., Hoffer L.D., Wiser A., Freedman R. Normalization of auditory physiology by cigarette smoking in schizophrenic patients. Am. J. Psychiatry. 150:1993;1856-1861.
2. Adler L.E., Hoffer L.J., Griffith J., Waldo M.C., Freedman R. Normalization by nicotine of deficient auditory sensory gating in the relatives of schizophrenics. Biol. Psychiatry. 32:1992;607-616.
3. Adler L.E., Olincy A., Waldo M.C., Harris J.G., Griffith J., Stevens K., Flach K., Nagamoto H., Bickford P., Leonard S., Freedman R. Schizophrenia, sensory gating, and nicotinic receptors. Schizophr. Bull. 24:1998;189-202.
4. Adler L.E., Pachtman E., Franks R., Pecevich M., Waldo M.C., Freedman R. Neurophysiological evidence for a defect in neuronal mechanisms involved in sensory gating in schizophrenia. Biol. Psychiatry. 17:1982;639-654.
5. Benhammou K., Drebing C., Logel J., Strook M., Lee M.J., Leonard S. Peripheral blood lymphocytes, neutrophils and immortalized lymphoblasts have defined patterns of nicotinic receptor subunit expression. J. Neurochem. 1999;. Submitted for publication.
6. Bickford-Wimer P.C., Nagamoto H., Johnson R., Adler L., Egan M., Rose G.M., Freedman R. Auditory sensory gating in hippocampal neurons: a model system in the rat. Biol. Psychiatry. 27:1990;183-192.
7. Boutros N.N., Zouridakis G., Overall J. Replication and extension of P50 findings in schizophrenia. Clin. Electroencephal. 22:1991;40-45.
8. Braff D.L., Grillon C., Geyer M.A. Gating and habituation of the startle reflex in schizophrenic patients. Arch. Gen. Psychiatry. 49:1992;206-215.
9. Braff D.L., Saccuzzo D.P. The time course of information-processing deficits in schizophrenia. Am. J. Psychiatry. 142:1985;170-174.
10. Breese C.R., Lee M.J., Adams C.E., Sullivan B., Logel J., Gillen K.M., Marks M.J., Collins A.C., Leonard S. Abnormal regulation of the high affinity nicotinic receptors in subjects with schizophrenia. Neuropsychopharmacology. 1999;. Submitted for publication.
11. 3H]nicotine binding in human postmortem brain. J. Pharmacol. Exp. Ther. 282:1997;7-13.
12. Brown R.A., Lewinsohn P.M., Seeley J.R., Wagner E.F. Cigarette smoking, major depression, and other psychiatric disorders among adolescents. J. Am. Acad. Child Adol. Psychiatry. 35:1996;1602-1610.
13. Carrasco-Serrano C., Campos-Caro A., Viniegra S., Ballesta J.J., Criado M. GC-and E-box motifs as regulatory elements in the proximal promoter region of the neuronal nicotinic receptor alpha-7 subunit gene. J. Biol. Chem. 273:1998;20021-20028.
14. Clarke P.B.S. The fall and rise of neuronal alpha-bungarotoxin binding proteins. Trends Pharmacol. Sci. 13:1992;407-413.
15. Clarke P.B.S. Nicotinic receptors in mammalian brain: localization and relation to cholinergic innervation. Prog. Brain Res. 98:1993;77-83.
16. Cloninger C.R. Turning point in the design of linkage studies of schizophrenia. Am. J. Med. Genet.: Neuropsychiatric Genet. 54:1994;83-92.
17. Couturier S., Bertrand D., Matter J.-M., Hernandez M.-C., Bertrand S., Millar N., Valera S., Barkas T., Ballivet M. A neuronal nicotinic acetylcholine receptor subunit α-7 is developmentally regulated and forms a homo-oligomeric channel blocked by α-bungarotoxin. Neuron. 5:1990;847-856.
18. Craddock N., Lendon C. Chromosome workshop: chromosomes 11, 14, and 15. Am. J. Med. Genet. 88:1999;244-254.
19. Edenberg H.J., Foroud T., Conneally P.M., Sorbel J.J., Carr K., Crose C., Zhao J., Miller M., Bowman E., Mayeda A., Rau N.L., Smiley C., Rice J.P., Goate A., Reich T., Stine O.C., McMahon F., DePaulo J.R., Meyers D., Detera-Wadleigh S.D., Goldin L.R., Gershon E.S., Blehar M.C., Nurnberger J.I. Jr. Initial genomic scan of the NIMH genetics initiative bipolar pedigrees: chromosomes 3, 5, 15, 16, 17, and 22. Am. J. Med. Genet. 74:1997;238-246.
20. Freedman R., Coon H., Myles-Worsley M., Orr-Urtreger A., Olincy A., Davis A., Polymeropoulos M., Holik J., Hopkins J., Hoff M., Rosenthal J., Waldo M.C., Reimherr R., Wender P., Yaw J., Young D.A., Breese C.R., Adams C., Patterson D., Adler L.E., Kruglyak L., Leonard S., Byerley W. Linkage of a neurophysiological deficit in schizophrenia to a chromosome 15 locus. Proc. Natl. Acad. Sci. 94:1997;587-592.
21. Freedman R., Hall M., Adler L.E., Leonard S. Evidence in postmortem brain tissue for decreased numbers of hippocampal nicotinic receptors in schizophrenia. Biol. Psychiatry. 38:1995;22-33.
22. Freedman R., Waldo M., Bickford-Wimer P., Nagamoto H. Elementary neuronal dysfunctions in schizophrenia. Schizophr. Res. 4:1991;233-243.
23. Gault J., Robinson M., Berger R., Drebing C., Logel J., Hopkins J., Moore T., Jacobs S., Meriwether J., Choi M.J., Kim E.J., Walton K., Buiting K., Davis A., Breese C.R., Freedman R., Leonard S. Genomic organization and partial duplication of the human α-7 neuronal nicotinic acetylcholine receptor gene. Genomics. 52:1998;173-185.
24. Goff D.C., Henderson D.C., Amico E. Cigarette smoking in schizophrenia: relationship to psychopathology and medication side effects. Am. J. Psychiatry. 149:1992;1189-1194.
25. Goff W.R., Williamson P.D., VanGilder J.C., Allison R., Fisher T.C. Neural origins of long latency evoked potentials recorded from the depth and from the cortical surface of the brain in man. Prog. Clin. Neurophysiol. 7:1980;126-145.
26. Greeman M., McClellan T.A. Negative effects of a smoking ban on an inpatient psychiatry service. Hosp. Comm. Psychiarty. 42:1991;408-412.
27. Hughes J.R., Hatsukami D.K., Mitchell J.E., Dahlgren I.A. Prevalence of smoking among psychiatric outpatients. Am. J. Psychiatry. 143:1986;993-997.
28. Jacobsen L.K., Rapoport J.L. Research update: childhood-onset schizophrenia: implications of clinical and neurobiological research. J. Child Psychol. Psych. Allied Discipl. 39:1998;101-113.
29. Kaufmann C.A., Suarez B., Malaspina D., Pepple J., Svrakic D., Markel P.D., Meyer J., Zambuto C.T., Schmitt K., Matise T.C., Harkavy F.J., Hampe C., Lee H., Shore D., Wynne D., Faraone S.V., Tsuang M.T., Cloninger C.R. NIMH genetics initiative millenium schizophrenia consortium: linkage analysis of African-American pedigrees. Am. J. Med. Genet. 81:1998;282-289.
30. Kirch D.G., Bigelow L.B., Weinberger D.R., Lawson W.B., Wyatt R.J. Polydipsia and chronic hyponatremia in schizophrenic inpatients. J. Clin. Psychiatry. 46:1985;179-181.
31. Lebargy F., Benhammou K., Morin D., Zini R., Urien S., Bree F., Bignon J., Branellec A., Lagrue G. Tobacco smoking induces expression of very-high-affinity nicotine binding sites on blood polymorphonuclear cells. Am. J. Respir. Crit. Care Med. 153:1996;1056-1063.
32. Lee M.J., Breese C.R., Leonard S. The effect of nicotine and haloperidol co-treatment on high and low affinity nicotinic and dopamine receptor levels in the rat brain. Neuropsychopharmacology. 1999;. Submitted for publication.
33. Leonard S., Adams C., Breese C.R., Adler L.E., Bickford P., Byerley W., Coon H., Griffith J.M., Miller C., Myles-Worsley M., Nagamoto H.T., Rollins Y., Stevens K.E., Waldo M., Freedman R. Nicotinic receptor function in schizophrenia. Schizophr. Bull. 22:1996;431-445.
34. Leonard S., Adler L.E., Olincy A., Breese C.R., Gault J., Ross R.G., Lee M., Cawthra E., Nagamoto H.T., Freedman R. The role of nicotine and nicotinic receptors in psychopathology. Arneriç S.P., Brioni J.D. Neuronal Nicotinic Receptors: Pharmacology and Therapeutic Opportunities. 1998;305-320 Wiley-Liss, New York, NY.
35. Leonard S., Gault J., Adams C., Breese C.R., Rollins Y., Adler L.E., Olincy A., Freedman R. Nicotinic receptors, smoking and schizophrenia. Restor. Neurol. Neurosci. 12:1998;195-201.
36. Leonard S., Gault J., Moore T., Hopkins J., Robinson M., Olincy A., Adler L.E., Cloninger C.R., Kaufmann C.A., Tsuang M.T., Faraone S.V., Malaspina D., Svrakic D.M., Freedman R. Further investigation of a chromosome 15 locus in schizophrenia: analysis of affected sibpairs from the NIMH genetics initiative. Am. J. Med. Genet. 81:1998;308-312.
37. Logel J., Breese C., Gillen K.M., Adams C.E., Leonard S. Expression of high and low affinity neuronal nicotinic receptors in tissues of neural crest origin. Soc. Neurosci. Abstr. 23:1997;382.
38. Lukas R.J., Norman S.A., Lucero L. Characterization of nicotinic acetylcholine receptors expressed by cells of the SH-SY5Y human neuroblastoma clonal line. Mol. Cell. Neurosci. 4:1993;1-12.
39. Luntz-Leybman V., Bickford P.C., Freedman R. Cholinergic gating of response to auditory stimuli in rat hippocampus. Brain Res. 587:1992;130-136.
40. McEvoy J.P., Freudenreich O., Levin E.D., Rose J.E. Haloperidol increases smoking in patients with schizophrenia. Psychopharmacology. 119:1995;124-126.
41. McEvoy J.P., Freudenreich O., McGee M., Vanderzwaag C., Levin E.D., Rose J.E. Clozapine decreases smoking in patients with chronic schizophrenia. Biol. Psychiatry. 37:1995;550-552.
42. McEvoy J.P., Freudenreich O., Wilson W.H. Smoking and therapeutic response to clozapine in patients with schizophrenia. Biol. Psychiatry. 46:1999;125-129.
43. McGehee D.S., Role L.W. Physiological diversity of nicotinic acetylcholine receptors expressed by vertebrate neurons. Annu. Rev. Physiol. 57:1995;521-546.
44. McGlashan T.H., Fenton W.S. The positive-negative distinction in schizophrenia: review of natural history validators. Gen. Psychiatry. 49:1992;63-72.
45. McGue M., Gottesman I.I. Genetic linkage in schizophrenia: perspectives from genetic epidemiology. Schizophr. Bull. 15:1989;453-464.
46. Meehl P.E. Schizotaxia, schizotypy, schizophrenia. Am. Psychol. 17:1962;827-838.
47. Menza M.A., Grossman N., VanHorn C., Cody R., Forman N. Smoking and movement disorders in psychiatric patients. Biol. Psychiatry. 30:1991;109-115.
48. Miller C., Freedman R. Medial septal neuron activity in relation to an auditory sensory gating paradigm. Neuroscience. 55:1993;373-380.
49. Nagamoto H.T., Adler L.E., Hea R.A., Griffith J.M., McRae K.A., Freedman R. Gating of auditory P50 in schizophrenics: unique effects of clozapine. Biol. Psychiatry. 40:1996;181-188.
50. Olincy A., Ross R.G., Young D.A., Roath M., Freedman R. Improvement in smooth pursuit eye movements after cigarette smoking in schizophrenic patients. Neuropsychopharmacology. 18:1998;175-185.
51. Olincy A., Young D.A., Freedman R. Increased levels of the nicotine metabolite cotinine in schizophrenic smokers compared to other smokers. Biol. Psychiatry. 42:1997;1-5.
52. Quik M., Chan J., Patrick J. α-Bungarotoxin blocks the nicotinic receptor mediated increase in cell number in a neuroendocrine cell line. Brain Res. 655:1994;161-167.
53. Reite M., Teale P., Zimmerman J.E., Davis K., Whalen J. Source location of a 50 msec latency auditory evoked field component. Electroencephalogr. Clin. Neurophysiol. 70:1988;490-498.
54. Reite M., Teale P., Zimmerman J.E., Davis K., Whalen J., Edrich J. Source origin of a 50-msec latency auditory evoked field component in young schizophrenic men. Biol. Psychiatry. 24:1988;495-506.
55. Riley B.P., Mogudi-Carter M., Jenkins R.J., Williamson R., Collier D.A., Murray R.M. Further suggestive evidence for involvement of the α-7 nicotinic cholinergic receptor gene on chromosome 15q13-q14 in schizophrenia. Am. J. Hum. Genet. 61:1997;232.
56. Risch N. Genetic linkage and complex diseases, with special reference to psychiatric disorders. Genet. Epidemiol. 7:1990;3-16.
57. Risch N., Merikangas K.R. Linkage studies of psychiatric disorders. Eur. Arch. Psych. Clin. Neurosci. 243:1993;143-149.
58. Rollins Y.D., Stevens K.E., Harris K.R., Hall M.E., Rose G.M., Leonard S. Reduction in auditory gating following intracerebroventricular application of α-bungarotoxin binding site ligands and α-7 antisense oligonucleotides. Soc. Neurosci. Abstr. 19:1993;837-837.
59. Romano S.J., Corriveau R.A., Schwarz R.I., Berg D.K. Expression of the nicotinic receptor alpha-7 gene in tendon and periosteum during early development. J. Neurochem. 68:1997;640-648.
60. Ross R.G., Harris J.G., Olincy A., Radant A., Adler L.E., Freedman R. Familial transmission of two independent saccadic abnormalities in schizophrenia. Schizophr. Res. 30:1998;59-70.
61. Ross R.G., Olincy A., Harris J.G., Radant A., Adler L.E., Freedman R. Anticipatory saccades during smooth pursuit eye movements and familial transmission of schizophrenia. Biol. Psychiatry. 44:1998;690-697.
62. Ross R.G., Olincy A., Harris J.G., Radant A., Hawkins M., Adler L.E., Freedman R. Evidence for bilineal inheritance of physiological indicators of risk in childhood-onset schizophrenia. Am. J. Med. Genet. 88:1999;188-199.
63. Séguéla P., Wadiche J., Dineley-Miller K., Dani J.A., Patrick J.W. Molecular cloning, functional properties, and distribution of rat brain α-7: a nicotinic cation channel highly permeable to calcium. J. Neurosci. 13:1993;596-604.
64. Stevens K.E., Freedman R., Collins A.C., Hall M., Leonard S., Marks M.J., Rose G.M. Genetic correlation of inhibitory gating of hippocampal auditory evoked response and alpha-bungarotoxin-binding nicotinic cholinergic receptors in inbred mouse strains. Brain Res. 15:1996;152-162.
65. Stevens K.E., Kem W.R., Mahnir V.M., Freedman R. Selective alpha-7-nicotinic agonists normalize inhibition of auditory response in DBA mice. Psychopharmacology. 136:1998;320-327.
66. Stitzel J.A., Farnham D.A., Collins A.C. Linkage of strain-specific nicotinic receptor alpha-7 subunit restriction fragment length polymorphisms with levels of alpha-bungarotoxin binding in brain. Mol. Brain Res. 43:1996;30-40.
67. Tsuang M.T. Genotypes, phenotypes, and the brain: a search for connections in schizophrenia. Br. J. Psychiatry. 163:1993;299-307.
68. Tsuang M.T., Faraone S.V. The genetic epidemiology of schizophrenia. Comp. Ther. 20:1994;130-135.
69. Venebles P. Input dysfunction in schizophrenia. Maher B.A. Progress in Experimental Personality Research. 1964;1-47 Academic Press, New York, NY.
70. Waldo M.C., Carey G., Myles-Worsley M., Cawthra E., Adler L.E., Nagamoto H.T., Wender P., Byerley W., Plaetke R., Freedman R. Codistribution of a sensory gating deficit and schizophrenia in multi-affected families. Psychiatry Res. 39:1991;257-268.
71. Waldo M., Myles-Worsley M., Madison A., Byerley W., Freedman R. Sensory gating deficits in parents of schizophrenics. Am. J. Med. Genet. 60:1995;506-511.
72. Wessler I., Kirkpatrick C.J., Racke K. Non-neuronal acetylcholine, a locally acting molecule, widely distributed in biological systems: expression and function in humans. Pharmacol. Ther. 77:1998;59-79.
73. Wonnacott S. α-Bungarotoxin binds to low-affinity nicotine binding sites in rat brain. J. Neurochem. 47:1986;1706-1712.UK.